{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:10:22Z","timestamp":1792203022863,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chemotherapy can cause cachexia, which consists of weight loss associated with muscle atrophy. The exact mechanisms underlying this skeletal muscle toxicity are largely unknown and co-therapies to attenuate chemotherapy-induced side effects are lacking. By using a rat model of cisplatin-induced cachexia, we here characterized the mitochondrial homeostasis in tibialis anterior cachectic muscle and evaluated the potential beneficial effects of the growth hormone secretagogues (GHS) hexarelin and JMV2894 in this setting. We found that cisplatin treatment caused a decrease in mitochondrial biogenesis (PGC-1\u03b1, NRF-1, TFAM, mtDNA, ND1), mitochondrial mass (Porin and Citrate synthase activity) and fusion index (MFN2, Drp1), together with changes in the expression of autophagy-related genes (AKT\/FoxO pathway, Atg1, Beclin1, LC3AII, p62) and enhanced ROS production (PRX\u00a0III, MnSOD). Importantly, JMV2894 and hexarelin are capable to antagonize this chemotherapy-induced mitochondrial dysfunction. Thus, our findings reveal a key-role played by mitochondria in the mechanism responsible for GHS beneficial effects in skeletal muscle, strongly indicating that targeting mitochondrial dysfunction might be a promising area of research in developing therapeutic strategies to prevent or limit muscle wasting in cachexia.<\/jats:p>","DOI":"10.1038\/s41598-017-13504-y","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T09:49:46Z","timestamp":1507283386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7005-8708","authenticated-orcid":false,"given":"Giuseppe","family":"Sirago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Fracasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Cormio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Alain","family":"Fehrentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-4621","authenticated-orcid":false,"given":"Jean","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Musicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Maria","family":"Camerino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Fonzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Torsello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Maria Serena","family":"Lezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Liantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palmiro","family":"Cantatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"13504_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale, M. J. Mechanisms of cancer cachexia. Physiol. Rev. \n                           89, 381\u2013410 (2009).","journal-title":"Physiol. Rev."},{"key":"13504_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. \n                           12, 489\u201395 (2011).","journal-title":"Lancet Oncol."},{"key":"13504_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.semcdb.2015.11.005","volume":"54","author":"JA Carson","year":"2016","unstructured":"Carson, J. A., Hardee, J. P. & VanderVeen, B. N. The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting. Semin. Cell Dev. Biol. \n                           54, 53\u201367 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"13504_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00520-009-0722-3","volume":"18","author":"G Mantovani","year":"2010","unstructured":"Mantovani, G. & Madeddu, C. Cancer cachexia: medical management. Support Care Cancer. \n                           18, 1\u20139 (2010).","journal-title":"Support Care Cancer."},{"key":"13504_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-017-0562-0","volume":"19","author":"LJ Anderson","year":"2017","unstructured":"Anderson, L. J., Albrecht, E. D. & Garcia, J. M. Update on management of cancer-related cachexia. Curr. Oncol. Rep. \n                           19, 3 (2017).","journal-title":"Curr. Oncol. Rep."},{"key":"13504_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jcsm.12023","volume":"6","author":"J Chen","year":"2015","unstructured":"Chen, J. et al. Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved. J. Cachexia Sarcopenia Muscle. \n                           6, 132\u201343 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"13504_CR7","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/hc3601.095575","volume":"104","author":"N Nagaya","year":"2001","unstructured":"Nagaya, N. et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation. \n                           104, 1430\u201335 (2001).","journal-title":"Circulation."},{"key":"13504_CR8","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1210\/en.2004-0569","volume":"145","author":"C De Vriese","year":"2004","unstructured":"De Vriese, C. et al. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology. \n                           145, 4997\u20135005 (2004).","journal-title":"Endocrinology."},{"key":"13504_CR9","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1021\/jm0704550","volume":"50","author":"A Moulin","year":"2007","unstructured":"Moulin, A. et al. Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations. J. Med. Chem. \n                           50, 5790\u2013806 (2007).","journal-title":"J. Med. Chem."},{"key":"13504_CR10","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1021\/jm070024h","volume":"50","author":"L Demange","year":"2007","unstructured":"Demange, L. et al. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. J. Med. Chem. \n                           50, 1939\u201357 (2007).","journal-title":"J. Med. Chem."},{"key":"13504_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/SPC.0000000000000012","volume":"7","author":"S Ali","year":"2013","unstructured":"Ali, S., Chen, J. A. & Garcia, J. M. Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment. Curr. Opin. Support. Palliat. Care. \n                           7, 368\u201375 (2013).","journal-title":"Curr. Opin. Support. Palliat. Care."},{"key":"13504_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel, J. S. et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. \n                           17, 519\u201331 (2016).","journal-title":"Lancet Oncol."},{"key":"13504_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00472","volume":"7","author":"R Barreto","year":"2016","unstructured":"Barreto, R. et al. Cancer and chemotherapy contribute to muscle loss by activating common signaling pathways. Front. Physiol. \n                           7, 472 (2016).","journal-title":"Front. Physiol."},{"key":"13504_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcdb.2015.09.002","volume":"54","author":"F Penna","year":"2016","unstructured":"Penna, F., Busquets, S. & Argil\u00e9s, J. M. Experimental cancer cachexia: Evolving strategies for getting closer to the human scenario. Semin. Cell Dev. Biol. \n                           54, 20\u20137 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"13504_CR15","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1210\/en.2013-1179","volume":"154","author":"JM Garcia","year":"2013","unstructured":"Garcia, J. M. et al. Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice. Endocrinology. \n                           154, 3118\u201329 (2013).","journal-title":"Endocrinology."},{"key":"13504_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.taap.2014.05.001","volume":"278","author":"H Sakai","year":"2014","unstructured":"Sakai, H. et al. Mechanisms of cisplatin-induced muscle atrophy. Toxicol. Appl. Pharmacol. \n                           278, 190\u20139 (2014).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"13504_CR17","doi-asserted-by":"publisher","unstructured":"Bresciani, E. et al. JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia. Endocrin. https:\/\/doi.org\/10.1007\/s12020-016-1184-2 (2016).","DOI":"10.1007\/s12020-016-1184-2"},{"key":"13504_CR18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jcsm.12185","volume":"8","author":"E Conte","year":"2017","unstructured":"Conte, E. et al. Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia. J. Cachexia Sarcopenia Muscle. \n                           8, 386\u2013404 (2017).","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"13504_CR19","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0891-5849(01)00517-2","volume":"30","author":"V Pesce","year":"2001","unstructured":"Pesce, V. et al. Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscle. Free Radic. Biol. Med. \n                           30, 1223\u201333 (2001).","journal-title":"Free Radic. Biol. Med."},{"key":"13504_CR20","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/j.bbagen.2014.03.004","volume":"1840","author":"A Picca","year":"2014","unstructured":"Picca, A. et al. A comparison among the tissue-specific effects of aging and calorie restriction on TFAM amount and TFAM-binding activity to mtDNA in rat. Biochim. Biophys. Acta. \n                           1840, 2184\u201391 (2014).","journal-title":"Biochim. Biophys. Acta."},{"key":"13504_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00422","volume":"6","author":"V Romanello","year":"2016","unstructured":"Romanello, V. & Sandri, M. Mitochondrial quality control and muscle mass maintenance. Front. Physiol. \n                           6, 422 (2016).","journal-title":"Front. Physiol."},{"key":"13504_CR22","first-page":"208","volume":"30","author":"HN Carter","year":"2015","unstructured":"Carter, H. N., Chen, C. C. & Hood, D. A. Mitochondria, muscle health, and exercise with advancing age. Physiology (Bethesda). \n                           30, 208\u201323 (2015).","journal-title":"Physiology (Bethesda)."},{"key":"13504_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s13539-012-0071-9","volume":"3","author":"CM Julienne","year":"2012","unstructured":"Julienne, C. M. et al. Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency. J. Cachexia Sarcopenia Muscle. \n                           3, 265\u201375 (2012).","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"13504_CR24","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.bbagen.2012.11.009","volume":"1830","author":"CC Fontes-Oliveira","year":"2013","unstructured":"Fontes-Oliveira, C. C. et al. Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency? Biochim. Biophys. Acta. \n                           1830, 2770\u20138 (2013).","journal-title":"Biochim. Biophys. Acta."},{"key":"13504_CR25","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2174\/1389450116666150416115721","volume":"17","author":"ST Isaac","year":"2016","unstructured":"Isaac, S. T., Tan, T. C. & Polly, P. Endoplasmic reticulum stress, calcium dysregulation and altered protein translation: intersection of processes that contribute to cancer cachexia induced skeletal muscle wasting. Curr. Drug Targets. \n                           17, 1140\u20136 (2016).","journal-title":"Curr. Drug Targets."},{"key":"13504_CR26","doi-asserted-by":"publisher","first-page":"43442","DOI":"10.18632\/oncotarget.9779","volume":"7","author":"R Barreto","year":"2016","unstructured":"Barreto, R. et al. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs. Oncotarget. \n                           7, 43442\u201360 (2016).","journal-title":"Oncotarget."},{"key":"13504_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/MCO.0000000000000174","volume":"18","author":"D Attaix","year":"2015","unstructured":"Attaix, D., Pichard, C. & Baracos, V. E. Muscle wasting: is mitochondrial dysfunction a key target? Curr. Opin. Clin. Nutr. Metab. Care. \n                           18, 213\u20134 (2015).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"13504_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1101\/gad.1177604","volume":"18","author":"DP Kelly","year":"2004","unstructured":"Kelly, D. P. & Scarpulla, R. C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. \n                           18, 357\u201368 (2004).","journal-title":"Genes Dev."},{"key":"13504_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mito.2015.10.001","volume":"25","author":"A Picca","year":"2015","unstructured":"Picca, A. & Lezza, A. M. Regulation of mitochondrial biogenesis through TFAM-mitochondrial DNA interactions: useful insights from aging and calorie restriction studies. Mitochondrion. \n                           25, 67\u201375 (2015).","journal-title":"Mitochondrion."},{"key":"13504_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2016.04.004","volume":"29","author":"CS Malarkey","year":"2016","unstructured":"Malarkey, C. S. et al. The sea urchin mitochondrial transcription factor A binds and bends DNA efficiently despite its unusually short C-terminal tail. Mitochondrion. \n                           29, 1\u20136 (2016).","journal-title":"Mitochondrion."},{"key":"13504_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-biochem-060815-014402","volume":"85","author":"CM Gustafsson","year":"2016","unstructured":"Gustafsson, C. M., Falkenberg, M. & Larsson, N. G. Maintenance and expression of mammalian mitochondrial DNA. Annu. Rev. Biochem. \n                           85, 133\u201360 (2016).","journal-title":"Annu. Rev. Biochem."},{"key":"13504_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-279","volume":"5","author":"A Cormio","year":"2012","unstructured":"Cormio, A. et al. Mitochondrial DNA content and mass increase in progression from normal to hyperplastic to cancer endometrium. BMC Res. Notes. \n                           5, 279 (2012).","journal-title":"BMC Res. Notes."},{"key":"13504_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","volume":"163","author":"GS Shadel","year":"2015","unstructured":"Shadel, G. S. & Horvath, T. L. Mitochondrial ROS signaling in organismal homeostasis. Cell. \n                           163, 560\u20139 (2015).","journal-title":"Cell."},{"key":"13504_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.freeradbiomed.2015.05.039","volume":"88","author":"G Hayashi","year":"2015","unstructured":"Hayashi, G. & Cortopassi, G. Oxidative stress in inherited mitochondrial diseases. Free Radic. Biol. Med. \n                           88, 10\u20137 (2015).","journal-title":"Free Radic. Biol. Med."},{"key":"13504_CR35","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1152\/ajpendo.00609.2011","volume":"303","author":"SK Powers","year":"2012","unstructured":"Powers, S. K., Wiggs, M. P., Duarte, J. A., Zergeroglu, A. M. & Demirel, H. A. Mitochondrial signaling contributes to disuse muscle atrophy. Am. J. Physiol. Endocrinol. Metab. \n                           303, E31\u20139 (2012).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"13504_CR36","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00280-016-3045-3","volume":"78","author":"JC Sorensen","year":"2016","unstructured":"Sorensen, J. C. et al. Mitochondria: inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting? Cancer Chemother. Pharmacol. \n                           78, 673\u201383 (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"13504_CR37","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.bbabio.2009.03.002","volume":"1787","author":"C Musicco","year":"2009","unstructured":"Musicco, C. et al. Accumulation of overoxidized Peroxiredoxin III in aged rat liver mitochondria. Biochim. Biophys. Acta. \n                           1787, 890\u20136 (2009).","journal-title":"Biochim. Biophys. Acta."},{"key":"13504_CR38","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1093\/hmg\/ddn230","volume":"17","author":"N Zhong","year":"2008","unstructured":"Zhong, N. & Xu, J. Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1\u03b1: regulation by SUMOylation and oxidation. Hum. Mol. Genet. \n                           17, 3357\u201367 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"13504_CR39","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cardiores.2005.01.026","volume":"66","author":"I Valle","year":"2005","unstructured":"Valle, I., Alvarez-Barrientos, A., Arza, E., Lamas, S. & Monsalve, M. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc. Res. \n                           66, 562\u201373 (2005).","journal-title":"Cardiovasc. Res."},{"key":"13504_CR40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.18632\/aging.100436","volume":"4","author":"AMY Shum","year":"2012","unstructured":"Shum, A. M. Y. et al. Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting. Aging (Albany NY). \n                           4, 133\u201343 (2012).","journal-title":"Aging (Albany NY)."},{"key":"13504_CR41","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bbamcr.2017.03.006","volume":"1864","author":"J Nan","year":"2017","unstructured":"Nan, J. et al. Molecular regulation of mitochondrial dynamics in cardiac disease. Biochim. Biophys. Acta. \n                           1864, 1260\u201373 (2017).","journal-title":"Biochim. Biophys. Acta."},{"key":"13504_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","volume":"117","author":"M Sandri","year":"2004","unstructured":"Sandri, M. et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. \n                           117, 399\u2013412 (2004).","journal-title":"Cell."},{"key":"13504_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bcp.2014.06.023","volume":"91","author":"A Mele","year":"2014","unstructured":"Mele, A. et al. Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes. Biochem. Pharmacol. \n                           91, 266\u201375 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"13504_CR44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.tcb.2010.03.002","volume":"20","author":"SF Funderburk","year":"2010","unstructured":"Funderburk, S. F., Wang, Q. J. & Yue, Z. The Beclin 1 -VPS34 complex- at the crossroads of autophagy and beyond. Trends Cell Biol. \n                           20, 355\u201362 (2010).","journal-title":"Trends Cell Biol."},{"key":"13504_CR45","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2006.10.003","volume":"4","author":"M Schuler","year":"2006","unstructured":"Schuler, M. et al. PGC1\u03b1 expression is controlled in skeletal muscles by PPAR\u03b2, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metabolism. \n                           4, 407\u201314 (2006).","journal-title":"Cell Metabolism."},{"key":"13504_CR46","first-page":"61","volume":"73","author":"RP Sharma","year":"1983","unstructured":"Sharma, R. P. & Edwards, I. R. Cis-platinum: subcellular distribution and binding to cytosolic ligands. Biochem. Pharmacol. \n                           73, 61\u201374 (1983).","journal-title":"Biochem. Pharmacol."},{"key":"13504_CR47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1042\/BJ20071615","volume":"414","author":"N Garrido","year":"2008","unstructured":"Garrido, N. et al. Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels. Biochem. J. \n                           414, 93\u2013102 (2008).","journal-title":"Biochem. J."},{"key":"13504_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-2-14","volume":"2","author":"JP White","year":"2012","unstructured":"White, J. P. et al. IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin\/+mouse. Skelet. Muscle. \n                           2, 14 (2012).","journal-title":"Skelet. Muscle."},{"key":"13504_CR49","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/rej.2009.0955","volume":"13","author":"V Pesce","year":"2010","unstructured":"Pesce, V. et al. Acetyl-L-carnitine supplementation to old rats partially reverts the age-related mitochondrial decay of soleus muscle by activating peroxisome proliferator-activated receptor gamma coactivator-1alpha-dependent mitochondrial biogenesis. Rejuvenation Res. \n                           13, 148\u201351 (2010).","journal-title":"Rejuvenation Res."},{"key":"13504_CR50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1042\/bj20020525","volume":"366","author":"E Wagner","year":"2002","unstructured":"Wagner, E. et al. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem. J. \n                           366, 777\u201385 (2002).","journal-title":"Biochem. J."},{"key":"13504_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/JES.0b013e3181911fa4","volume":"37","author":"AE Rossi","year":"2009","unstructured":"Rossi, A. E., Boncompagni, S. & Dirksen, R. T. Sarcoplasmic reticulum-mitochondrial symbiosis: bidirectional signaling in skeletal muscle. Exerc. Sport Sci. Rev. \n                           37, 29\u201335 (2009).","journal-title":"Exerc. Sport Sci. Rev."},{"key":"13504_CR52","doi-asserted-by":"crossref","first-page":"35358","DOI":"10.18632\/oncotarget.6139","volume":"6","author":"L Pietrangelo","year":"2015","unstructured":"Pietrangelo, L. et al. Age-dependent uncoupling of mitochondria from Ca2+ release units in skeletal muscle. Oncotarget. \n                           6, 35358\u201371 (2015).","journal-title":"Oncotarget."},{"key":"13504_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition. Autophagy. \n                           12, 1\u2013222 (2016).","journal-title":"Autophagy."},{"key":"13504_CR54","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/MCO.0000000000000048","volume":"17","author":"F Penna","year":"2014","unstructured":"Penna, F., Baccino, F. M. & Costelli, P. Coming back: autophagy in cachexia. Curr. Opin. Clin. Nutr. Metab. Care. \n                           17, 241\u20136 (2014).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"13504_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep30340","volume":"6","author":"Z Aversa","year":"2016","unstructured":"Aversa, Z. et al. Autophagy is induced in the skeletal muscle of cachectic cancer patients. Sci. Rep. \n                           6, 30340 (2016).","journal-title":"Sci. Rep."},{"key":"13504_CR56","doi-asserted-by":"publisher","first-page":"20405","DOI":"10.1073\/pnas.0911570106","volume":"106","author":"T Wenz","year":"2009","unstructured":"Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M. & Moraes, C. T. Increased muscle PGC-1\u03b1 expression protects from sarcopenia and metabolic disease during aging. Proc. Natl. Acad. Sci. USA. \n                           106, 20405\u201310 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"13504_CR57","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.biocel.2013.04.023","volume":"45","author":"M Sandri","year":"2013","unstructured":"Sandri, M. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitine proteasome. Int. J. Biochem. Cell Biol. \n                           45, 2121\u20139 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"13504_CR58","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/jcsm.12045","volume":"7","author":"K Sakuma","year":"2016","unstructured":"Sakuma, K. et al. p62\/SQSTM1 but not LC3 is accumulated in sarcopenic muscle of mice. J. Cachexia Sarcopenia Muscle. \n                           7, 204\u201312 (2016).","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"13504_CR59","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.celrep.2014.07.061","volume":"8","author":"S Carnio","year":"2014","unstructured":"Carnio, S. et al. Autophagy impairment in muscle induces neuromuscular junction degeneration and precocious aging. Cell Reports \n                           8, 1509\u201321 (2014).","journal-title":"Cell Reports"},{"key":"13504_CR60","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1210\/en.2013-1334","volume":"154","author":"A Liantonio","year":"2013","unstructured":"Liantonio, A. et al. Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl\/nonpeptidyl structure. Endocrinol. \n                           154, 3764\u201375 (2013).","journal-title":"Endocrinol."},{"key":"13504_CR61","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1210\/en.2015-1353","volume":"156","author":"M Tamaki","year":"2015","unstructured":"Tamaki, M. et al. Improvement of physical decline through combined effects of muscle enhancement and mitochondrial activation by a gastric hormone ghrelin in male 5\/6Nx CKD model mice. Endocrinology. \n                           156, 3638\u201348 (2015).","journal-title":"Endocrinology."},{"key":"13504_CR62","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/brain\/awt343","volume":"137","author":"C Giordano","year":"2014","unstructured":"Giordano, C. et al. Efficient mitochondrial biogenesis drives incomplete penetrance in Leber\u2019s hereditary optic neuropathy. Brain. \n                           137, 335\u201353 (2014).","journal-title":"Brain."},{"key":"13504_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.364","volume":"6","author":"L Giordano","year":"2015","unstructured":"Giordano, L. et al. Cigarette toxicity triggers Leber\u2019s hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways. Cell Death Dis. \n                           6, e2021 (2015).","journal-title":"Cell Death Dis."},{"key":"13504_CR64","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cmet.2011.04.011","volume":"14","author":"C Viscomi","year":"2011","unstructured":"Viscomi, C. et al. In vivo correction of COX deficiency by activation of the AMPK\/PGC-1\u03b1 axis. Cell. Metab. \n                           14, 80\u201390 (2011).","journal-title":"Cell. Metab."},{"key":"13504_CR65","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2014.04.001","volume":"19","author":"R Cerutti","year":"2014","unstructured":"Cerutti, R. et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab. \n                           19, 1042\u20139 (2014).","journal-title":"Cell Metab."},{"key":"13504_CR66","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. \n                           29, e45 (2001).","journal-title":"Nucleic Acids Res."},{"key":"13504_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065167","volume":"8","author":"S Pierno","year":"2013","unstructured":"Pierno, S. et al. Paracrine effects of IGF-1 overexpression on the functional decline due to skeletal muscle disuse: molecular and functional evaluation in hindlimb unloaded MLC\/mIgf-1 transgenic mice. PLoS One. \n                           8, e65167 (2013).","journal-title":"PLoS One."},{"key":"13504_CR68","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. \n                           55, 611\u201322 (2009).","journal-title":"Clin. Chem."},{"key":"13504_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0076-6879(69)13005-0","volume":"13","author":"PA Srere","year":"1969","unstructured":"Srere, P. A. Cytrate synthase. Methods Enzymol. \n                           13, 3\u20135 (1969).","journal-title":"Methods Enzymol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13504-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13504-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13504-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:49:30Z","timestamp":1671796170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13504-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13504"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13504-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]},"assertion":[{"value":"19 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13017"}}